Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study of CM082 Combined With JS001 in the Treatment of Advanced Mucosal Melanoma.

NCT03602547 is registered in ClinicalTrials.gov with AnewPharma as lead sponsor.

NCT NCT03602547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03602547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study of CM082 Combined With JS001 in the Treatment of Advanced Mucosal Melanoma.
Lead sponsor
AnewPharma
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2018
Completion date
June 30, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucosal melanoma